Re-elevation of high-sensitivity c-reactive protein but not the von Willebrand factor after withdrawing atorvastatin therapy in patients with unstable angina undergoing coronary artery stenting: A kinetic study

International Heart Journal

Volumn 47, Issue 4, 2006, Pages 501-509

  Yip, Hon Kan ^a   Youssef, Ali A ^b   Chua, Sarah ^a   Hung, Wei Chin ^a   Chen, Yen Hsun ^a   Yeh, Kuo Ho ^a   Wu, Chiung Jen ^a   Hang, Chi Ling ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b Suez Canal University Hospital   (Egypt)

Author keywords

Atorvastatin; Endothelial dysfunction; Inflammation

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY STENT; DRUG DOSE REGIMEN; DRUG FATALITY; ENDOTHELIUM; FEMALE; HEART DISEASE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT WITHDRAWAL; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; PYRROLES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 33749066008     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.47.501     Document Type: Article

References (23)

1. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
2. Libby P, Geng YJ, Sukhova GK, Simon DI, Lee RT. Molecular determinants of atherosclerotic plaque vulnerability. Ann N Y Acad Sci 1997; 811: 134-42; discussion 142-5. (Review)
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26. (Review)
4. Pasceri V, Willerson JT, Yeh ET. Direct promflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102; 2165-8.
5. Mueller C, Buettner HJ, Hodgson JM, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002; 105: 1412-5.
6. Yip HK, Wu CJ, Chang HW, et al. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest 2004; 126: 1417-22.
7. Yip HK, Hung WC, Yang CH, et al. Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting. Circ J 2005; 69: 1202-7.
8. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 237-42.
9. Ridker PM, Rifai N, Rose L, Buring JE, Cook N. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of fast cardiovascular events. N Engl J Med 2002; 347: 1557-65.
10. Szmitko PE, Wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation 2003; 108: 1917-23. (Review)
11. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054-9. (Review)
12. Yip HK, Wu CJ, Yang CH, et al. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting. Circ J 2005; 69: 890-5.
13. van de Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C; DALI-Study Group. Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. Atherosclerosis 2003; 166: 129-35.
14. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 2003; 107: 3141-5.
15. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-4.
16. Kobayashi S, Inoue N, Ohashi Y, et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003; 23: 1398-404.
17. Yip HK, Hang CL, Fang CY, et al. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. Chest 2005; 127: 803-8.
18. Burke AP, Tracy RP, Kologie F, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105: 2019-23.
19. Ishikawa T, Hatakeyama K, Imamura T, et al. Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 2003; 91: 287-92.
20. Yip HK, Sun CK, Chang LT, Wu CJ. Strong correlation between serum levels of inflammatory mediators and their distribution in infarct coronary artery. Circ J 2006; 70: 838-45.
21. Yeung AC, Tsao P. Statin therapy: beyond cholesterol lowering and anti-inflammatory effects. Circulation 2002; 105: 2937-8.
22. Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol 2003; 91(suppl): 9B-13. (Review)
23. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 2002; 106: 1962-7.